Activation of aldosterone-induced mineralocorticoids can negatively impact insulin secretion and sensitivity, which are crucial factors in the progression of T2DM.[48,49] Joshua et al[50] suggested that an increase in log-aldosterone levels was connected with a 44% higher occurrence of T2DM (P < .01). This evidence concerns the gene INS and type 2 diabetes mellitus.